Novalis LifeSciences — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Animolanimol-discovery.comJul 2022
Animol Discovery develops small-molecule pharmaceuticals for companion and farm animals, targeting unmet veterinary needs.
AgTechAI & Machine LearningBiotechBoston, US
Philip Austin(Executive Officer, Director)Andrew Plant(Executive Officer, Director)
BoardMichelle Haven(Director)
Board seatMarijn Dekkers· per SEC Form D
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.